Published on 22/12/2025

TMF Retention Periods After a Clinical Trial: Global Guidelines Explained

Why Retaining TMF Documents Post-Trial is Critical

Clinical trial documents don’t lose relevance when a study ends. Regulatory bodies require sponsors, CROs, and sites to retain essential records for years—sometimes decades—after trial completion. This long-term retention ensures that all trial activities remain traceable, auditable, and compliant with Good Clinical Practice (GCP) standards.

Whether you’re dealing with paper-based records or an eTMF system, understanding how long to retain TMF documents is vital to staying inspection-ready and avoiding compliance pitfalls.

Overview of Global TMF Retention Guidelines

The required retention duration varies by region and regulatory authority. Here’s a summary of the most commonly referenced requirements:

Sponsors conducting multi-national trials must adhere to the longest applicable retention period across participating countries.

What Documents Must Be Retained?

Retention applies to all documents listed in ICH E6(R2) Section 8 as “essential.” These include, but are not limited to:

• Final protocol and amendments
• Investigator Brochure (IB)
• Informed Consent Forms (ICFs)
• Monitoring reports
• Site delegation logs
• Regulatory approvals and ethics committee correspondence
• Final Clinical Study Report (CSR)

The documents must remain accessible, readable, and protected from unauthorized access or deterioration for the full retention duration.

For a TMF retention checklist and audit tools, visit PharmaSOP.in.

Managing eTMF Retention for Long-Term Compliance

As more sponsors shift to electronic Trial Master Files (eTMFs), digital retention strategies are essential. Retaining eTMFs isn’t simply about storing files—it involves maintaining the entire audit trail, metadata, and file integrity for years, sometimes decades.

Best practices for eTMF retention include:

• Archiving in non-proprietary, long-term readable formats (e.g., PDF/A, TIFF)
• Retaining system-generated metadata, version history, and audit logs
• Maintaining validated infrastructure that complies with 21 CFR Part 11 and Annex 11
• Defining SOPs for eTMF system access, backup, migration, and decommissioning

For example, an eTMF archived in 2024 must still be retrievable and readable in 2049 if the trial is governed under EMA’s 25-year rule.

Who Owns TMF Retention Responsibilities?

According to ICH and FDA guidance, the sponsor holds ultimate responsibility for TMF retention, even if the trial is outsourced to a CRO.

Key assignments should include:

• Sponsor QA: Responsible for archiving policies and oversight
• CRO Document Manager: Maintains records and performs archival migration
• TMF Custodian: Maintains log of archive access, backups, and physical location

Contracts with CROs must clearly define retention timelines and responsibilities post-database lock or trial closeout.

Audit Risks During the Retention Period

Retaining TMFs isn’t enough—they must be retrievable and complete when regulators come knocking. Retention periods are subject to audit, especially in post-marketing safety reviews or follow-up inspections.

Questions inspectors may ask during TMF retention audits include:

• “Can you retrieve a final signed ICF from a trial conducted 10 years ago?”
• “Has the sponsor verified ongoing access to archived digital records?”
• “Who has access to these files and how is access logged?”

Deficiencies in document traceability or access can lead to audit findings and regulatory action.

Document Disposal After Retention Period

After the retention period expires, sponsors may initiate secure destruction. However, this must be done under formal SOPs and in line with contractual and legal obligations.

Steps include:

• Internal sign-off from QA and Legal before destruction
• Documenting the destruction process with a certificate
• Destroying both paper and digital files through validated processes
• Notifying all relevant partners, including CROs, of final archive status

Records should never be destroyed if there is an ongoing litigation, regulatory hold, or unresolved safety concern.

Conclusion: TMF Retention is More Than a Timeline

Retaining TMF documents for 2, 15, or 25 years isn’t just about holding onto files—it’s about maintaining compliance, audit readiness, and data integrity. From system validation to staff training and SOP enforcement, every aspect of the TMF lifecycle must align with retention rules.

Whether storing physical binders or cloud-based eTMFs, organizations must have a sustainable retention infrastructure in place. And that begins with a clear understanding of global regulatory expectations.

For global retention checklists, archive planning tools, and SOP templates, visit PharmaValidation.in.